Tabula Rasa HealthCare Chariman and CEO Calvin H. Knowlton delivered the keynote speech at the American Society for Automation in Pharmacy.
Tabula Rasa HealthCare Chariman and CEO Calvin H. Knowlton was the keynote speaker at The American Society for Automation in Pharmacy (ASAP) MidYear Conference in Palm Beach, Flor. on June 22. Knowlton addressed the issue of adverse drug events (ADEs) and how technology can provide solutions.
“Regarding adverse drug events, unintentional misuse and overdose is looming,” Knowlton said. “As pharmacists, we must collaborate with our software friends to provide us with the medication risk mitigation tools we need to effect change and eliminate ADEs, which are often cited as the fourth leading cause of death. It is time to integrate the science that underlies our medication safety metrics into our pharmacy technology and systems.”
The conference highlighted technology’s role in pharmacy, particularly regarding ADEs, regulatory and dispensing requirements, cyber security in healthcare, specialty pharmacy and more.
Knowlton is the founder of Tabula Rasa HealthCare (TRHC), a healthcare technology company optimizing medication safety by developing new medication risk mitigation and medication decision support tools.
Knowlton has won awards for his leadership in pharmacy, business and philanthropy in his career of more than 30 years including the 2003 and 2013 Ernest and Young Entrepreneur of the Year Award for the greater Philadelphia region and the 2016 Philadelphia Technology CEO of the year. In 2015, Knowlton was awarded the Remington Honor Medal, which is pharmacy’s highest honor.
Contributing to his profession and the community, Knowlton has served as the national president for the American College of Apothecaries, president of the American Pharmacists Association (APhA) for two terms and president of the American Pharmacists Association Foundation. He is the board chair of the Evergreens Continuing Care Retirement Community and serves on the Board of Cooper Medical School of Rowan University. He recently finished terms on the Boards of Coriell Institute for Medical Research, St Christopher’s Hospital for Children in Philadelphia and the Settlement Music School in Philadelphia.
Knowlton received his pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary and his PhD in Pharmacoeconomics from the University of Maryland. He served as professor and department chair for the University of the Sciences in Philadelphia in the 1990s. He has authored and co-authored textbooks, book chapters and articles focused on the role and responsibility of pharmacists in the outcomes of patient-centered medication care.
